Results 101 to 110 of about 10,950 (228)
Treatment of neuromyelitis optica: an evidence based review
Arquivos de Neuro-Psiquiatria, 2012 Neuromyelitis optica (NMO) is an inflammatory disease of the central nervous system characterized by severe optic neuritis and transverse myelitis, usually with a relapsing course. Aquaporin-4 antibody is positive in a high percentage of NMO patients and
Douglas Sato +3 more
doaj +1 more source
A Novel Perspective on Multiple Sclerosis: Morphological Shifts in Immune Cell Populations
Progress in Neurology and Psychiatry, Volume 30, Issue 2, May 2026.ABSTRACT This study aims to investigate expanded hematological data in multiple sclerosis (MS) and evaluate their association with disease severity. A total of 190 patients participated in the study. For this purpose, expanded hemocytometry data were compared between 120 patients diagnosed with MS and 70 healthy controls.
Hayrettin Yavuz +8 more
wiley +1 more source
Journal of Neuroinflammation, 2012 Background In multiple sclerosis relapses refractory to intravenous corticosteroid therapy, plasma exchange is recommended. Immunoadsorption (IA) is regarded as an alternative therapy, but its efficacy and putative mechanism of action still needs to be ...
Koziolek Michael J +8 more
doaj +1 more source
Neurological complications of immune checkpoint inhibitors: what happens when you \u27take the brakes off\u27 the immune system. [PDF]
, 2018 Patients with advanced malignancies treated with immune checkpoint inhibitors are at increased risk for developing immune-related neurological complications.
Dalakas, Marinos
core +1 more source
Clinical and Experimental Neuroimmunology, Volume 17, Issue 2, May 2026.ABSTRACT Background Some patients with myelin oligodendrocyte glycoprotein antibody‐associated disease (MOGAD) experience multiple relapses and poor prognoses; however, the factors associated with these outcomes are unclear. This study aimed to identify factors associated with relapse and neurological prognosis in patients with MOGAD.
Masashi Nakamura +4 more
wiley +1 more source
Clinical and Experimental Neuroimmunology, Volume 17, Issue 2, May 2026.ABSTRACT Background Satralizumab is used for the treatment of neuromyelitis optica spectrum disorder (NMOSD). However, there are currently no standardized guidelines regarding the method or speed of steroid tapering after its introduction. In 2023, we proposed a method to commence tapering prednisolone at a rate of 1 mg every 4 weeks, starting 8 weeks ...
Kiyotaka Nakamagoe +4 more
wiley +1 more source
Landmark Studies in Neuro-Ophthalmology
Philippine Journal of Ophthalmology, 2019 High-quality clinical evidence, derived from well-designed and implemented clinical trials, serves to advance clinical care and to allow physicians to provide the most effective treatments to their patients.
Franz Marie Cruz, MD +1 more
doaj
Manual cataract extraction via a subconjunctival limbus oblique incision for mature cataracts
Indian Journal of Ophthalmology, 2014 Aims: To report the technique and outcomes of sutureless manual cataract extraction via a subconjunctival limbus oblique incision for mature cataracts.
J Yang, P Lai, D Wu, Z Long
doaj +1 more source
Severe and disseminated atypical mycobacteriosis of the skin under immunosuppression
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Veronika Zenderowski +6 more
wiley +1 more source